Impact of SGLT2 inhibitors in patients with Fabry disease.

Galafold (migalastat) - Amicus

http://www.ncbi.nlm.nih.gov/pubmed/41801437

Albina Nowak; Christine Kurschat; Christoph Wanner; Constantin Gatterer; Eva Brand; Fabian Braun; Gere Sunder-Plassmann; Malte Lenders; Markus Cybulla; Peter Nordbeck; Sima Canaan-Kühl; Victoria Sokalski

Mar 9, 2026